Movella (MVLA) 10-K 31 Mar 23 2022 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 20, 2023	Jun. 30, 2022
Document Information [Line Items]
Entity Registrant Name	MOVELLA HOLDINGS INC.
Document Type	10-K
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 318,825,000
Amendment Flag	false
Entity Central Index Key	0001839132
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Annual Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	DE
Entity File Number	001-40074
Entity Tax Identification Number	95-1575384
Entity Address, Address Line One	Suite 110
Entity Address, Address Line Two	3535 Executive Terminal Drive
Entity Address, City or Town	Henderson
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89052
City Area Code	310
Local Phone Number	481-1800
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		50,693,308
Auditor Name	WithumSmith+Brown, PC
Auditor Location	New York, New York
Auditor Firm ID	100
Common stock, $0.00001 par value per share
Document Information [Line Items]
Trading Symbol	MVLA
Title of 12(b) Security	Common stock, $0.00001 par value per share
Security Exchange Name	NASDAQ
Warrants, each warrant exercisable for one share of common stock at an exercise price of $11.50
Document Information [Line Items]
Trading Symbol	MVLAW
Title of 12(b) Security	Warrants, each warrant exercisable for one share of common stock at an exercise price of $11.50
Security Exchange Name	NASDAQ

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 76,535	$ 21,217
Prepaid expenses	82,593	713,426
Total current assets	159,128	734,643
Investments held in Trust Account	328,636,388	325,028,452
Total Assets	328,795,516	325,763,095
Current liabilities:
Accounts payable	301,335	200,984
Accrued expenses	6,945,000	330,565
Due to related party	61,116	61,116
Note payable	1,000,000	250,000
Total current liabilities	8,307,451	842,665
Derivative warrant liabilities	2,472,500	6,342,500
Deferred underwriting commissions	0	11,375,000
Total liabilities	10,779,951	18,560,165
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,500,000 shares at redemption value of approximately $10.11 and $10.00 as of December 31, 2022 and 2021, respectively	328,536,388	325,000,000
Shareholders' Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2022 and 2021
Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; no non-redeemable shares issued and outstanding as of December 31, 2022 and 2021
Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 8,125,000 shares issued and outstanding as of December 31, 2022 and 2021	813	813
Additional paid-in capital
Accumulated deficit	(10,521,636)	(17,797,883)
Total shareholders' deficit	(10,520,823)	(17,797,070)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	$ 328,795,516	$ 325,763,095

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, authorized	1,000,000	1,000,000
Preference shares, issued	0	0
Preference shares, outstanding	0	0
Ordinary shares, issued	32,500,000	32,500,000
Ordinary shares, outstanding	32,500,000	32,500,000
Class A Ordinary Shares
Ordinary shares subject to possible redemption, per share (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares subject to possible redemption	32,500,000	32,500,000
Ordinary shares subject to possible redemption, par value (in Dollars per share)	$ 10.11	$ 10
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, authorized	300,000,000	300,000,000
Ordinary shares, issued	0	0
Ordinary shares, outstanding	0	0
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, authorized	30,000,000	30,000,000
Ordinary shares, issued	8,125,000	8,125,000
Ordinary shares, outstanding	8,125,000	8,125,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
General and administrative expenses	$ 7,920,300	$ 1,367,321
General and administrative expenses—related party	120,000	110,000
Loss from operations	(8,040,300)	(1,477,321)
Other income (expenses):
Change in fair value of derivative warrant liabilities	3,870,000	9,997,500
Gain from settlement of deferred underwriting commissions	345,800
Offering costs associated with derivative warrant liabilities		(575,330)
Income from investments held in Trust Account	3,607,935	28,452
Net income (loss)	$ (216,565)	$ 7,973,301
Class A Ordinary Shares
Other income (expenses):
Weighted average shares outstanding of ordinary share, basic (in Shares)	32,500,000	28,136,986
Weighted Average Number of Shares Outstanding, Diluted	32,500,000	28,136,986
Basic net income (loss) per share (in Dollars per share)	$ (0.01)	$ 0.22
Diluted net income (loss) per share, Class B ordinary share (in Dollars per share)	$ (0.01)	$ 0.22
Class B Ordinary Shares
Other income (expenses):
Weighted average shares outstanding of ordinary share, basic (in Shares)	8,125,000	8,041,096
Weighted Average Number of Shares Outstanding, Diluted	8,125,000	8,125,000
Basic net income (loss) per share (in Dollars per share)	$ (0.01)	$ 0.22
Weighted average shares outstanding of Class B ordinary share (in Shares)	8,125,000	8,125,000
Diluted net income (loss) per share, Class B ordinary share (in Dollars per share)	$ (0.01)	$ 0.22

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)	Total	Additional Paid-in Capital	Accumulated Deficit	Class A Ordinary Shares	Class B Ordinary Shares
Balance at Dec. 31, 2020	$ 17,000	$ 24,137	$ (8,000)		$ 863
Balance (in Shares) at Dec. 31, 2020					8,625,000
Excess cash received over the fair value of the private warrants	2,040,000	2,040,000
Accretion of Class A ordinary shares subject to possible redemption amount	(27,827,371)	(2,064,137)	(25,763,234)
Forfeiture of Class B ordinary shares		50			$ (50)
Forfeiture of Class B ordinary shares (in Shares)					(500,000)
Subsequent measurement of Class A ordinary shares subject to redemption against additional paid-in capital		(50)	50
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount	17,947,372
Net loss	7,973,301		7,973,301
Balance at Dec. 31, 2021	(17,797,070)		(17,797,883)		$ 813
Balance (in Shares) at Dec. 31, 2021					8,125,000
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount	7,492,812		7,492,812
Net loss	(216,565)		(216,565)
Balance at Dec. 31, 2022	$ (10,520,823)		$ (10,521,636)		$ 813
Balance (in Shares) at Dec. 31, 2022					8,125,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 4,767,175	$ (216,565)	$ 7,973,301
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	(6,104,920)	(3,870,000)	(9,997,500)
Gain from settlement of deferred underwriting commissions allocated to derivative warrant liabilities	(190,190)	(345,800)	0
Offering costs associated with derivative warrant liabilities	0		575,330
Income from investments held in Trust Account	1,323,982	(3,607,935)	(28,452)
Changes in operating assets and liabilities:
Prepaid expenses	(458,459)	630,832	(696,426)
Accounts payable	7,679	100,350	200,984
Accrued expenses	1,906,957	6,614,436	235,566
Net cash used in operating activities	(478,822)	(694,682)	(1,737,197)
Cash Flows from Investing Activities:
Cash deposited in Trust Account			(325,000,000)
Net cash used in investing activities			(325,000,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party		750,000	392,358
Repayment of note payable to related party			(129,181)
Proceeds received from initial public offering			325,000,000
Proceeds received from private placement			8,500,000
Offering costs paid			(7,004,763)
Net cash provided by financing activities		750,000	326,758,414
Net increase in cash		55,318	21,217
Cash—beginning of the year	$ 21,217	21,217
Cash—end of the year		76,535	21,217
Supplemental disclosure of noncash financing activities:
Offering costs included in accrued expenses			70,000
Offering costs paid by related party under promissory note			47,937
Deferred underwriting commissions in connection with the initial public offering			11,375,000
Extinguishment of deferred underwriting commissions allocated to Public Shares		$ 11,029,200	$ 0

Description of Organization and

Description of Organization and Business Operations	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Description of Organization and Business Operations	Note 1—Description of Organization and Business Operations Movella Holdings Inc., formerly known as Pathfinder Acquisition Corporation prior to February 10, 2023 (“Closing Date”) (the “Company”), was a blank check company incorporated as a Cayman Islands exempted company on December 18, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). Business Combination On the Closing Date, the Company consummated the previously announced Merger pursuant to that certain Business Combination Agreement dated October 3, 202 2 In connection with the domestication of Pathfinder as a Delaware corporation (the “Domestication”), on the Closing Date prior to the Effective Time (as defined below): (i) each issued and outstanding Class A ordinary share, $0.0001 par value per share (“Class A ordinary shares”), and each issued and outstanding Class B ordinary share, $0.0001 par value per share (“Class B ordinary shares”), of Pathfinder were converted into one share of common stock, $0.00001 par value per share, of New Movella (“New Movella Common Stock”); (ii) each issued and outstanding whole warrant to purchase Class A ordinary shares of Pathfinder was automatically converted into a warrant to purchase one share of New Movella Common Stock at an exercise price of $11.50 per share on the terms and subject to the conditions set forth in the Warrant Agreement, dated as of February 16, 2021, between Pathfinder and Continental Stock Transfer & Trust Company (the “Pathfinder Warrant Agreement”); (iii) the governing documents of Pathfinder were amended and restated and became the certificate of incorporation and the bylaws of New Movella; and (iv) Pathfinder’s name changed to “Movella Holdings Inc.” In connection with clauses (i) and (ii) of this paragraph, each issued and outstanding unit of Pathfinder issued in its initial public offering (“Pathfinder Units”) (each Pathfinder Unit consisting of one Class A ordinary share of Pathfinder and one-fifth of and one-fifth of On the Closing Date, promptly following the consummation of the Domestication, Merger Sub merged with and into Movella (the “Merger”), with Movella continuing as the surviving company in the Merger and, after giving effect to the Merger, Movella became a wholly owned subsidiary of New Movella (the time that the Merger became effective being referred to as the “Effective Time”). See the Company’s Current Report on Form 8-K filed Business Prior to the Business Combination As of December 31, 2022, the Company had not yet commenced operations. All activity for the period from December 18, 2020 (inception) through December 31, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below, and since the Company’s Initial Public Offering, the search for a business combination target. The Company had not generated any operating revenues as of December 31, 2022. The Company generated non-operating The Company’s sponsor was Pathfinder Acquisition LLC, a Delaware limited liability company (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on February 16, 2021. On February 19, 2021, the Company consummated its Initial Public Offering of 32,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 2,500,000 additional Units to partially cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $325.0 million, and incurring offering costs of approximately $18.5 million, of which approximately $11.4 million was for deferred underwriting commissions (see Note 6 of the prospectus to exercise the remaining portion of its option to purchase up to Units at the Initial Public Offering price to cover over-allotments, if any. On April 2, 2021, the over-allotment option on the remaining Units expired unexercised by the underwriters. On September 27, 2022, Deutsche Bank Securities, Inc. irrevocably waived its rights to the deferred underwriting commissions in the amount of approximately $ million due under the underwriting agreement consummated in connection with the Initial Public Offering. On October 12, 2022, RBC Capital Markets, LLC irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement in connection with the Initial Public Offering. On October 29, 2022, Stifel, Nicolaus & Company, Inc. irrevocably waived its rights to the deferred underwriting commissions in the amount of approximately $ million due under the underwriting agreement consummated in connection with the Initial Public Offering (see Note 6 Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,250,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $2.00 per Private Placement Warrant, generating gross proceeds to the Company of $ (Note 5 Upon the closing of the Initial Public Offering and the Private Placement, $325.0 million ($10.00 Liquidity and Capital Resources As of December 31, 2022, the Company had approximately $77,000 in its operating bank accounts and a working capital deficit of approximately $8.1 million Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares, and a loan of approximately $129,000 pursuant to the IPO Note issued to the Sponsor (as defined in Note 5 5 Note 5 On February 10, 2023, the Company completed a Business Combination with Movella Inc. and closed the related financing agreements in connection therewith. As a result, management believes that the Company will have sufficient liquidity to fund its operations through one year from the date of this filing.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Restatement of Previously Issued Financial Statements	Note 2—Restatement of Previously Issued Financial Statements The Company had recognized a liability upon closing of their initial public offering in February 2021 for a portion of the underwriter’s commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial discount to the securities sold in the initial public offering. On September 27, 2022, Deutsche Bank Securities, Inc. irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement. The Company recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statements of operations for the three and nine months ended September 30, 2022. Upon subsequent review and analysis, management concluded that the Company should have recognized the portion allocated to Public Shares as an adjustment to the carrying value of the Class A ordinary shares subject to possible redemption and the remaining balance as a gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities. Therefore, the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded that the Company’s previously issued interim financial statements as of September 30, 2022 (the “Quarterly Report”) should no longer be relied upon and that it is appropriate to restate the Quarterly Report. As such, the Company will restate its financial statements in this Form 10-K. The previously filed financial statements for the three and nine months ended September 30, 2022, as filed with the Securities and Exchange Commission (“SEC”) on November 14, 2022 (the “Original Filing”) should no longer be relied upon. Impact of the Restatement The impact of the restatement on the statements of operations, statement of changes in stockholders’ deficit and statement of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statements of Operations: For the Three Months Ended September 30, 2022 As Previously Restatement As Restated Loss from operations (2,302,238 ) – (2,302,238 ) Other income (expenses) Change in fair value of derivative warrant liabilities 1,159,920 – 1,159,920 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,256,250 (6,066,060 ) 190,190 Offering costs associated with derivative warrant liabilities – – – Income from investments held in Trust Account 1,108,635 – 1,108,635 Net income 6,222,567 (6,066,060 ) 156,507 Weighted average shares outstanding of Class A ordinary share, basic and diluted 32,500,000 – 32,500,000 Basic net income per share, Class A ordinary share 0.15 (0.15 ) 0.00 Weighted average shares outstanding of Class B ordinary share, basic 8,125,000 – 8,125,000 Basic net income per share, Class B ordinary share 0.15 (0.15 ) 0.00 Weighted average shares outstanding of Class B ordinary share, diluted 8,125,000 – 8,125,000 Diluted net income per share, Class B ordinary share 0.15 (0.15 ) 0.00 For the Nine Months Ended September 30, 2022 As Previously Restatement As Restated Loss from operations (2,851,917 ) – (2,851,917 ) Other income (expenses) : Change in fair value of derivative warrant liabilities 6,104,920 – 6,104,920 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,256,250 (6,066,060 ) 190,190 Offering costs associated with derivative warrant liabilities – – – Income from investments held in Trust Account 1,323,982 – 1,323,982 Net income 10,833,235 (6,066,060 ) 4,767,175 Weighted average shares outstanding of Class A ordinary share, basic and diluted 32,500,000 – 32,500,000 Basic net income per share, Class A ordinary share 0.27 (0.15 ) 0.12 Weighted average shares outstanding of Class B ordinary share, basic 8,125,000 – 8,125,000 Basic net income per share, Class B ordinary share 0.27 (0.15 ) 0.12 Weighted average shares outstanding of Class B ordinary share, diluted 8,125,000 – 8,125,000 Diluted net income per share, Class B ordinary share 0.27 (0.15 ) 0.12 Statement of Changes in Shareholders’ Deficit: For the Nine Months Ended September 30, 2022 As Previously Restatement As Adjustment for accretion of Class A ordinary shares subject to possible redemption amount - accumulated deficit (1,252,434 ) 6,066,060 4,813,626 Statement of Cash Flows: For the Nine Months Ended September 30, 2022 As Previously Restatement As Restated Net income 10,833,235 (6,066,060 ) 4,767,175 Adjustments to reconcile net income to net cash used in operating activities: Change in fair value of derivative warrant liabilities (6,104,920 ) – (6,104,920 ) Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities (6,256,250 ) 6,066,060 (190,190 ) Offering costs associated with derivative warrant liabilities – – – Income from investments held in Trust Account (1,323,982 ) – (1,323,982 ) Changes in operating assets and liabilities: Prepaid expenses 458,459 – 458,459 Accounts payable 7,679 – 7,679 Accrued expenses 1,906,957 – 1,906,957 Net cash used in operating activities (478,822 – (478,822 )

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Note 3—Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Principles of Consolidation The consolidated financial statements of the Company include its wholly-owned subsidiaries in connection with the Business Combination. All inter-company accounts and transactions are eliminated in consolidation . Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021. Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximate the carrying amounts represented in the consolidated balance sheets, except for derivative warrant liabilities (see note 10 Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised or expire. The initial fair value of the Public Warrants issued in connection with the Public Offering and the fair value of the Private Placement Warrants have been estimated using a binomial lattice model in a risk-neutral framework. The fair value of the Public Warrants as of December 31, 2022 and 2021 is based on observable listed prices for such warrants. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. Derivative warrant liabilities are classified as non-current Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s consolidated balance sheets. The Company has elected to recognize changes in redemption value immediately as they occur and adjust the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in Net income per ordinary share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the Over-allotment Units) and the private placement warrants to purchase an aggregate of 10,750,000 Class A ordinary shares in the calculation of diluted income per share, because in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the years ended December 31, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The Company has considered the effect of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of the over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares. The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share of ordinary shares: For The Years Ended December 31, 2022 2021 Class A Class B Class A Class B Net income (loss) per ordinary share: Numerator: Allocation of net income (loss), basic $ (173,252) $ (43,313) $ 6,201,121 $ 1,772,180 Allocation of net income (loss), diluted $ (173,252) $ (43,313) $ 6,186,773 $ 1,786,528 Denominator: Basic weighted average ordinary shares outstanding 32,500,000 8,125,000 28,136,986 8,041,096 Diluted weighted average ordinary shares outstanding 32,500,000 8,125,000 28,136,986 8,125,000 Basic net income (loss) per ordinary share $ (0.01) $ (0.01) $ 0.22 $ 0.22 Diluted net income (loss) per ordinary share $ (0.01) $ (0.01) $ 0.22 $ 0.22 Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes were not levied on the Company for the year ended December 31, 2022. Consequently, income taxes are not reflected in the Company’s consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2022
Initial Public Offering [Abstract]
Initial Public Offering	Note 4—Initial Public Offering On February 19, 2021, the Company consummated its Initial Public Offering of 32,500,000 Units, including 2,500,000 per Unit, generating gross proceeds of $ million, and incurring offering costs of approximately $ million, of which approximately $11.4 million was for deferred underwriting commissions. The underwriters have 45 days from the effective date of the prospectus to exercise the remaining portion of its option to purchase up to Units at the Initial Public Offering price to cover over-allotments. On April 2, 2021, the over-allotment option on the remaining Units expired unexercised by the underwriters; thus, Class B ordinary shares were forfeited. On September 27, 2022, Deutsche Bank Securities, Inc. irrevocably waived its rights to the deferred underwriting commissions in the amount of approximately $ million due under the underwriting agreement consummated in connection with the Initial Public Offering. On October 12, 2022, RBC Capital Markets, LLC irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement in connection with the Initial Public Offering. On October 29, 2022, Stifel, Nicolaus & Company, Inc. irrevocably waived its rights to the deferred underwriting commissions in the amount of approximately $ million due under the underwriting agreement consummated in connection with the Initial Public Offering (see Note 6 Each Unit consists of one Class A ordinary share and one-fifth 9

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5—Related Party Transactions Founder Shares On December 28, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 7,906,250 Class B ordinary shares (the “Founder Shares”). On February 16, 2021, the Company effected a share dividend of 718,750 Class B ordinary shares to the Sponsor, resulting in there being an aggregate of 8,625,000 Class B ordinary shares outstanding. The Sponsor agreed to forfeit up to an aggregate of 1,125,000 Founder Shares to the extent that the option to purchase additional Units is not exercised in full by the underwriters or is reduced, so that the Founder Shares will represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriters partially exercised their over-allotment option to purchase an additional 2,500,000 Units on February 19, 2021 and on April 2, 2021, the over-allotment option on the remaining Units expired unexercised by the underwriters; thus, 500,000 Class B ordinary shares were forfeited by the Sponsor. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or earlier if, subsequent to the initial Business Combination, the closing price of the Class A ordinary share equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,250,000 Private Placement Warrants to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $2.00 per Private Placement Warrant, generating gross proceeds to the Company of $8.5 million. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable 10 The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On December 23, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “IPO Note”). The IPO Note was non-interest In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors will loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $2.00 per warrant. The warrants would be identical to the Private Placement Warrants. Promissory Note On July 15, 2021, the Company issued a promissory note (the “Promissory Note”) to the Sponsor providing for borrowings by the Company in an aggregate principal amount of up to $500,000, which was subsequently amended and restated to increase available borrowings to up to $750,000 on May 24, 2022. The Promissory Note was issued to allow for borrowings from time to time by the Company for working capital expenses. On October 3, 2022, the Company amended and restated the Promissory Note issued to the Sponsor to allow for an increase in available borrowings from time to time of an additional $500,000, for an aggregate principal amount of up to $1,250,000. The Promissory Note was issued to allow for borrowings from time to time by the Company for working capital expenses. The Promissory Note (i) bears no interest, (ii) is due and payable upon the earlier of (a) February 19, 2023 and (b) the date that the Company consummates an initial business combination and (iii) may be prepaid at any time. As of December 31, 2022 and 2021, the Company had borrowed $1.0 million and $250,000 in loans under the Promissory Note, respectively. On January 27, 2023, the Company amended and restated the Promissory Note (the “A&R Promissory Note”) issued to the Sponsor to allow for an increase in available borrowings from time to time of an additional $250,000, for an aggregate principal amount of up to $1,500,000. The A&R Promissory Note was issued to allow for borrowings from time to time by the Company for working capital expenses. The A&R Promissory Note (i) bears no interest, (ii) is due and payable upon the earlier of (a) April 30, 2023 or ( b Administrative Services Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor $10,000 per month for office space, secretarial and administrative services provided to the Company. For the years ended December 31, 2022 and 2021, the Company incurred expenses of $120,000 and $110,00 under this agreement, respectively. As of December 31, 2022 and 2021, the Company had accrued approximately $169,000 and $100,000 respectively, for services in connection with such agreement on the accompanying consolidated balance sheets in accounts payable. Due to Related Parties In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6—Commitments and Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement entered into on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were entitled to an underwriting discount of $ per unit, or $ million in the aggregate, payable upon the closing of the Initial Public Offering. In addition, $ per unit, or approximately $ million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On September 27, 2022, Deutsche Bank Securities, Inc. irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement of approximately $6.3 million. The Company derecognized approximately $ million of the commissions waiver allocated to Public Shares to the carrying value of the Class A ordinary shares subject to possible redemption and the remaining balance of approximately $190,000 as a gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities. On October 12, 2022, RBC Capital Markets, LLC irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement in connection with the Initial Public Offering. On October 29, 2022, Stifel, Nicolaus & Company, Inc. irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement of approximately $ million. The Company derecognized approximately $5.0 million of the commissions waiver allocated to Public Shares to the carrying value of the Class A ordinary shares subject to possible redemption and the remaining balance of approximately $156,000 as a gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these consolidated financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these consolidated financial statements. Consulting Agreements The Company has an agreement with third party consultant to provide certain advisory services to the Company relating to identification of and negotiation with potential targets, assistance with due diligence, marketing, financial analyses and investor relations, pursuant to which the consultants have agreed to defer their fees and have payment of such fees to be solely contingent on the Company closing an initial Business Combination. As of December 31, 2022 and 2021, the Company has incurred approximately $ million and $ million, respectively, in contingent fees pursuant to these agreements. The Company recognized an expense for these services as of December 31, 2022 when the performance trigger was considered probable, which in this case occurred upon the closing of a Business Combination with Movella Inc.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 7—Class A Ordinary Shares Subject to Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 300,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2022 and 2021, there were 32,500,000 shares of Class A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the consolidated balance sheets. The Class A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: Gross proceeds $ 325,000,000 Less: Fair value of Public Warrants at issuance (9,880,000 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (17,947,372 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 27,827,372 Class A ordinary shares subject to possible redemption as of December 31, 2021 325,000,000 Plus: Waiver of offering costs allocated to Class A ordinary shares subject to 11,029,200 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption amount (7,492,812 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 $ 328,536,388

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	Note 8—Shareholders’ Deficit Preference Shares— no Class A Ordinary Shares— equity (see Note 7). Class B Ordinary Shares or in part, so that the Class B ordinary Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law; provided that only holders of Class B ordinary shares will have the right to vote on the appointment of directors prior to or in connection with the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted one-to-one.

Warrants

Warrants	12 Months Ended
	Dec. 31, 2022
Warrant [Abstract]
Warrants	Note 9 – Warrants As of December 31, 2022 and 2021, the Company had 6,500,000 of Public Warrants and 4,250,000 of Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement relating to the Public Warrants. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60 th The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 10-trading The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except (i) that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (ii) except as described below, the Private Placement Warrants will be non-redeemable Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; • if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10—Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. December 31, 2022 Description Quoted Significant Significant Assets: Investments held in Trust Account—money market fund $ 328,636,388 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ — $ 1,495,000 $ — Derivative warrant liabilities—Private placement warrants $ — $ 977,500 $ — December 31, 2021 Description Quoted Significant Significant Assets: Investments held in Trust Account—money market fund $ 325,028,452 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ — $ 3,835,000 $ — Derivative warrant liabilities—Private placement warrants $ — $ 2,507,500 $ — Level 1 assets include investments in money market funds that invest solely in U.S. Treasury securities with an original maturity of 185 days or less. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement in April 2021, when the Public Warrants were separately listed and traded in an active market. Subsequently in December 2021, the estimated fair value of Public Warrants was transferred from a Level 1 measurement to Level 2 measurement due to lack of trading activity. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement in April 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. There were no other transfers to/from Levels 1, 2, and 3 during the years ended December 31, 2022 and 2021. The initial fair value of the Public and Private Placement Warrants, issued in connection with the Initial Public Offering, has been estimated using a binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value. The estimated fair value of the Public and Private Placement Warrants, prior to Public Warrants being traded in an active market, is determined using Level 3 inputs. Inherent in a binomial lattice model are assumptions related to the Unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The Unit price is based on the publicly traded price of the Units as of the measurement date. The Company estimated the volatility for the Public and Private Placement Warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the Public and Private Placement Warrants. The term to expiration was calculated as the contractual term of the Public and Private Placement Warrants, assuming one year to a Business Combination from the IPO date. Finally, the Company does not anticipate paying a dividend. The most significant input was volatility and significant increases (decreases) in the expected volatility in isolation would result in a significantly higher (lower) fair value measurement. The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the year ended December 31, 2021 is summarized as follows: Derivative warrant liabilities at January 1, 2021 $ — Issuance of Public and Private Warrants 16,340,000 Transfer of Public Warrants to Level 1 (8,710,000 ) Transfer of Private Warrants to Level 2 (5,695,000 ) Change in fair value of derivative warrant liabilities (1,935,000 ) Derivative warrant liabilities at December 31, 2021 $ —

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 11—Subsequent Events The Company has evaluated subsequent events and transactions that occurred after the balance sheet date and up to the date consolidated financial statements were available to be issued. Based upon this review, except as noted in Note 1 and Note 5 On February 8, 2023, the Company held an extraordinary general meeting (the “Extraordinary General Meeting”) at which the Company’s shareholders considered and adopted, among other matters, the Business Combination Agreement and the business combination with Movella Inc. In connection with the Extraordinary General Meeting, holders of 28,961,090 Class A ordinary shares exercised their right to redeem those shares for cash at a redemption price of approximately $10.16 per share, for an aggregate redemption amount of approximately $294.2 million. Following such redemptions, 3,538,910 Class A ordinary shares remained outstanding, representing approximately $36.2 million cash in trust available

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements of the Company include its wholly-owned subsidiaries in connection with the Business Combination. All inter-company accounts and transactions are eliminated in consolidation .
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximate the carrying amounts represented in the consolidated balance sheets, except for derivative warrant liabilities (see note 10
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised or expire. The initial fair value of the Public Warrants issued in connection with the Public Offering and the fair value of the Private Placement Warrants have been estimated using a binomial lattice model in a risk-neutral framework. The fair value of the Public Warrants as of December 31, 2022 and 2021 is based on observable listed prices for such warrants. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. Derivative warrant liabilities are classified as non-current
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s consolidated balance sheets. The Company has elected to recognize changes in redemption value immediately as they occur and adjust the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in
Net income per ordinary share	Net income per ordinary share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the Over-allotment Units) and the private placement warrants to purchase an aggregate of 10,750,000 Class A ordinary shares in the calculation of diluted income per share, because in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the years ended December 31, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The Company has considered the effect of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of the over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares. The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share of ordinary shares: For The Years Ended December 31, 2022 2021 Class A Class B Class A Class B Net income (loss) per ordinary share: Numerator: Allocation of net income (loss), basic $ (173,252) $ (43,313) $ 6,201,121 $ 1,772,180 Allocation of net income (loss), diluted $ (173,252) $ (43,313) $ 6,186,773 $ 1,786,528 Denominator: Basic weighted average ordinary shares outstanding 32,500,000 8,125,000 28,136,986 8,041,096 Diluted weighted average ordinary shares outstanding 32,500,000 8,125,000 28,136,986 8,125,000 Basic net income (loss) per ordinary share $ (0.01) $ (0.01) $ 0.22 $ 0.22 Diluted net income (loss) per ordinary share $ (0.01) $ (0.01) $ 0.22 $ 0.22
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes were not levied on the Company for the year ended December 31, 2022. Consequently, income taxes are not reflected in the Company’s consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Summary Of Impact Of Restatement Of Financial Statements	The impact of the restatement on the statements of operations, statement of changes in stockholders’ deficit and statement of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statements of Operations: For the Three Months Ended September 30, 2022 As Previously Restatement As Restated Loss from operations (2,302,238 ) – (2,302,238 ) Other income (expenses) Change in fair value of derivative warrant liabilities 1,159,920 – 1,159,920 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,256,250 (6,066,060 ) 190,190 Offering costs associated with derivative warrant liabilities – – – Income from investments held in Trust Account 1,108,635 – 1,108,635 Net income 6,222,567 (6,066,060 ) 156,507 Weighted average shares outstanding of Class A ordinary share, basic and diluted 32,500,000 – 32,500,000 Basic net income per share, Class A ordinary share 0.15 (0.15 ) 0.00 Weighted average shares outstanding of Class B ordinary share, basic 8,125,000 – 8,125,000 Basic net income per share, Class B ordinary share 0.15 (0.15 ) 0.00 Weighted average shares outstanding of Class B ordinary share, diluted 8,125,000 – 8,125,000 Diluted net income per share, Class B ordinary share 0.15 (0.15 ) 0.00 For the Nine Months Ended September 30, 2022 As Previously Restatement As Restated Loss from operations (2,851,917 ) – (2,851,917 ) Other income (expenses) : Change in fair value of derivative warrant liabilities 6,104,920 – 6,104,920 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,256,250 (6,066,060 ) 190,190 Offering costs associated with derivative warrant liabilities – – – Income from investments held in Trust Account 1,323,982 – 1,323,982 Net income 10,833,235 (6,066,060 ) 4,767,175 Weighted average shares outstanding of Class A ordinary share, basic and diluted 32,500,000 – 32,500,000 Basic net income per share, Class A ordinary share 0.27 (0.15 ) 0.12 Weighted average shares outstanding of Class B ordinary share, basic 8,125,000 – 8,125,000 Basic net income per share, Class B ordinary share 0.27 (0.15 ) 0.12 Weighted average shares outstanding of Class B ordinary share, diluted 8,125,000 – 8,125,000 Diluted net income per share, Class B ordinary share 0.27 (0.15 ) 0.12 Statement of Changes in Shareholders’ Deficit: For the Nine Months Ended September 30, 2022 As Previously Restatement As Adjustment for accretion of Class A ordinary shares subject to possible redemption amount - accumulated deficit (1,252,434 ) 6,066,060 4,813,626 Statement of Cash Flows: For the Nine Months Ended September 30, 2022 As Previously Restatement As Restated Net income 10,833,235 (6,066,060 ) 4,767,175 Adjustments to reconcile net income to net cash used in operating activities: Change in fair value of derivative warrant liabilities (6,104,920 ) – (6,104,920 ) Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities (6,256,250 ) 6,066,060 (190,190 ) Offering costs associated with derivative warrant liabilities – – – Income from investments held in Trust Account (1,323,982 ) – (1,323,982 ) Changes in operating assets and liabilities: Prepaid expenses 458,459 – 458,459 Accounts payable 7,679 – 7,679 Accrued expenses 1,906,957 – 1,906,957 Net cash used in operating activities (478,822 – (478,822 )

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of basic and diluted net income (loss) per share	The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share of ordinary shares: For The Years Ended December 31, 2022 2021 Class A Class B Class A Class B Net income (loss) per ordinary share: Numerator: Allocation of net income (loss), basic $ (173,252) $ (43,313) $ 6,201,121 $ 1,772,180 Allocation of net income (loss), diluted $ (173,252) $ (43,313) $ 6,186,773 $ 1,786,528 Denominator: Basic weighted average ordinary shares outstanding 32,500,000 8,125,000 28,136,986 8,041,096 Diluted weighted average ordinary shares outstanding 32,500,000 8,125,000 28,136,986 8,125,000 Basic net income (loss) per ordinary share $ (0.01) $ (0.01) $ 0.22 $ 0.22 Diluted net income (loss) per ordinary share $ (0.01) $ (0.01) $ 0.22 $ 0.22

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of class A ordinary shares subject to possible redemption	The Class A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: Gross proceeds $ 325,000,000 Less: Fair value of Public Warrants at issuance (9,880,000 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (17,947,372 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 27,827,372 Class A ordinary shares subject to possible redemption as of December 31, 2021 325,000,000 Plus: Waiver of offering costs allocated to Class A ordinary shares subject to 11,029,200 Less: Adjustment for accretion of Class A ordinary shares subject to possible redemption amount (7,492,812 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 $ 328,536,388

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities that are measured at fair value	December 31, 2022 Description Quoted Significant Significant Assets: Investments held in Trust Account—money market fund $ 328,636,388 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ — $ 1,495,000 $ — Derivative warrant liabilities—Private placement warrants $ — $ 977,500 $ — December 31, 2021 Description Quoted Significant Significant Assets: Investments held in Trust Account—money market fund $ 325,028,452 $ — $ — Liabilities: Derivative warrant liabilities—Public warrants $ — $ 3,835,000 $ — Derivative warrant liabilities—Private placement warrants $ — $ 2,507,500 $ —
Schedule of change in fair value of derivative warrant liabilities	Derivative warrant liabilities at January 1, 2021 $ — Issuance of Public and Private Warrants 16,340,000 Transfer of Public Warrants to Level 1 (8,710,000 ) Transfer of Private Warrants to Level 2 (5,695,000 ) Change in fair value of derivative warrant liabilities (1,935,000 ) Derivative warrant liabilities at December 31, 2021 $ —

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)			1 Months Ended			12 Months Ended
	Oct. 29, 2022	Sep. 27, 2022	Feb. 19, 2021	Dec. 28, 2020	Dec. 28, 2020	Dec. 31, 2022	Oct. 03, 2022	Dec. 31, 2021
Description of Organization and Business Operations (Details) [Line Items]
Operating bank accounts						$ 77,000
Payment from the sponsor						25,000
Loan amount						129,000
Working capital loans						1,000,000		$ 250,000
Deferred underwriting commissions	$ 5,100,000	$ 6,300,000
Working Capital Deficit						8,100,000
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units issued by the company (in Shares)			32,500,000
Gross proceeds			$ 325,000,000
Offering costs			18,500,000
Deferred underwriting commissions.			$ 11,400,000
Option to purchase (in Shares)			2,000,000
Amount of net proceeds from sale of units						$ 325,000,000
Net proceeds per share (in Dollars per share)						$ 10
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units issued by the company (in Shares)			2,500,000
Price per share (in Dollars per share)			$ 10
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units issued by the company (in Shares)						4,250,000
Gross proceeds						$ 8,500,000
Class of warrant or right, exercise price of warrants or rights						$ 2
Price per share (in Dollars per share)						2
Class A Ordinary Shares [Member]
Description of Organization and Business Operations (Details) [Line Items]
Class of warrant or right, exercise price of warrants or rights						11.5
Price per share (in Dollars per share)						11.5
Ordinary shares, par value (in Dollars per share)						0.0001		$ 0.0001
Class A Ordinary Shares [Member] | Domestication [Member]
Description of Organization and Business Operations (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)							$ 0.0001
Class A Ordinary Shares [Member] | Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)						$ 11.5
New Movella Common Stock [Member] | Domestication [Member]
Description of Organization and Business Operations (Details) [Line Items]
Class of warrant or right, exercise price of warrants or rights							11.5
Common stock, conversion basis						one share of common stock, $0.00001 par value per share, of New Movella (“New Movella Common Stock”); (ii) each issued and outstanding whole warrant to purchase Class A ordinary shares of Pathfinder was automatically converted into a warrant to purchase one share of New Movella Common Stock at an exercise price of $11.50 per share on the terms
Class B Ordinary Shares [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units issued by the company (in Shares)				7,906,250	7,906,250
Ordinary shares, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Class B Ordinary Shares [Member] | Domestication [Member]
Description of Organization and Business Operations (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)							$ 0.0001

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Summary of Impact of Restatement of Financial Statements (Details) - USD ($)			3 Months Ended	9 Months Ended	12 Months Ended
	Oct. 29, 2022	Sep. 27, 2022	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Loss from operations			$ (2,302,238)	$ (2,851,917)	$ (8,040,300)	$ (1,477,321)
Other income (expenses)
Change in fair value of derivative warrant liabilities			1,159,920	6,104,920	(3,870,000)	(9,997,500)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	$ 156,000	$ 190,000	190,190	190,190	345,800	0
Offering costs associated with derivative warrant liabilities			0	0		575,330
Income from investments held in Trust Account			1,108,635	1,323,982	3,607,935	28,452
Net income			156,507	4,767,175	(216,565)	7,973,301
Statement of Stockholders' Equity [Abstract]
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount - accumulated deficit				4,813,626	7,492,812	17,947,372
Statement of Cash Flows [Abstract]
Net income			156,507	4,767,175	(216,565)	7,973,301
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities				(6,104,920)	(3,870,000)	(9,997,500)
Gain from settlement of deferred underwriting commissions allocated to derivative warrant liabilities	$ (156,000)	$ (190,000)	$ (190,190)	(190,190)	(345,800)	0
Offering costs associated with derivative warrant liabilities				0		575,330
Income from investments held in Trust Account				(1,323,982)	3,607,935	28,452
Changes in operating assets and liabilities:
Prepaid expenses				458,459	(630,832)	696,426
Accounts payable				7,679	100,350	200,984
Accrued expenses				1,906,957	6,614,436	235,566
Net cash used in operating activities				$ (478,822)	$ (694,682)	$ (1,737,197)
Common Class A [Member]
Other income (expenses)
Weighted average ordinary shares outstanding, Basic			32,500,000	32,500,000	32,500,000	28,136,986
Weighted average ordinary shares outstanding, Diluted			32,500,000	32,500,000	32,500,000	28,136,986
Basic net income ordinary share, Basic			$ 0	$ 0.12	$ (0.01)	$ 0.22
Basic net income ordinary share, Diluted					$ (0.01)	$ 0.22
Common Class B [Member]
Other income (expenses)
Weighted average ordinary shares outstanding, Basic			8,125,000	8,125,000	8,125,000	8,041,096
Weighted average ordinary shares outstanding, Diluted			8,125,000	8,125,000	8,125,000	8,125,000
Basic net income ordinary share, Basic			$ 0	$ 0.12	$ (0.01)	$ 0.22
Basic net income ordinary share, Diluted			$ 0	$ 0.12	$ (0.01)	$ 0.22
Previously Reported [Member]
Income Statement [Abstract]
Loss from operations			$ (2,302,238)	$ (2,851,917)
Other income (expenses)
Change in fair value of derivative warrant liabilities			1,159,920	6,104,920
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities			6,256,250	6,256,250
Offering costs associated with derivative warrant liabilities			0	0
Income from investments held in Trust Account			1,108,635	1,323,982
Net income			6,222,567	10,833,235
Statement of Stockholders' Equity [Abstract]
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount - accumulated deficit				(1,252,434)
Statement of Cash Flows [Abstract]
Net income			6,222,567	10,833,235
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities				(6,104,920)
Gain from settlement of deferred underwriting commissions allocated to derivative warrant liabilities			$ (6,256,250)	(6,256,250)
Offering costs associated with derivative warrant liabilities				0
Income from investments held in Trust Account				(1,323,982)
Changes in operating assets and liabilities:
Prepaid expenses				458,459
Accounts payable				7,679
Accrued expenses				1,906,957
Net cash used in operating activities				$ (478,822)
Previously Reported [Member] | Common Class A [Member]
Other income (expenses)
Weighted average ordinary shares outstanding, Basic			32,500,000	32,500,000
Weighted average ordinary shares outstanding, Diluted			32,500,000	32,500,000
Basic net income ordinary share, Basic			$ 0.15	$ 0.27
Previously Reported [Member] | Common Class B [Member]
Other income (expenses)
Weighted average ordinary shares outstanding, Basic			8,125,000	8,125,000
Weighted average ordinary shares outstanding, Diluted			8,125,000	8,125,000
Basic net income ordinary share, Basic			$ 0.15	$ 0.27
Basic net income ordinary share, Diluted			$ 0.15	$ 0.27
Restatement Adjustment [Member]
Income Statement [Abstract]
Loss from operations			$ 0	$ 0
Other income (expenses)
Change in fair value of derivative warrant liabilities			0	0
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities			(6,066,060)	(6,066,060)
Offering costs associated with derivative warrant liabilities			0	0
Income from investments held in Trust Account			0	0
Net income			(6,066,060)	(6,066,060)
Statement of Stockholders' Equity [Abstract]
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount - accumulated deficit				6,066,060
Statement of Cash Flows [Abstract]
Net income			(6,066,060)	(6,066,060)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities				0
Gain from settlement of deferred underwriting commissions allocated to derivative warrant liabilities			$ 6,066,060	6,066,060
Offering costs associated with derivative warrant liabilities				0
Income from investments held in Trust Account				0
Changes in operating assets and liabilities:
Prepaid expenses				0
Accounts payable				0
Accrued expenses				0
Net cash used in operating activities				$ 0
Restatement Adjustment [Member] | Common Class A [Member]
Other income (expenses)
Basic net income ordinary share, Basic			$ (0.15)	$ (0.15)
Restatement Adjustment [Member] | Common Class B [Member]
Other income (expenses)
Weighted average ordinary shares outstanding, Basic			0	0
Weighted average ordinary shares outstanding, Diluted			0	0
Basic net income ordinary share, Basic			$ (0.15)	$ (0.15)
Basic net income ordinary share, Diluted			$ (0.15)	$ (0.15)

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) shares
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Federal depository insurance coverage (in Dollars) | $	$ 250,000
Private placement warrants to purchase ordinary shares	10,750,000
Class A Ordinary Shares [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Ordinary shares subject to possible redemption	32,500,000

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share of ordinary shares - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Class A
Numerator:
Allocation of net income (loss), basic			$ (173,252)	$ 6,201,121
Allocation of net income (loss), diluted			$ (173,252)	$ 6,186,773
Denominator:
Basic weighted average ordinary shares outstanding	32,500,000	32,500,000	32,500,000	28,136,986
Weighted average ordinary shares outstanding, Diluted	32,500,000	32,500,000	32,500,000	28,136,986
Basic net income (loss) per ordinary share	$ 0	$ 0.12	$ (0.01)	$ 0.22
Diluted net income (loss) per ordinary share			$ (0.01)	$ 0.22
Class B
Numerator:
Allocation of net income (loss), basic			$ (43,313)	$ 1,772,180
Allocation of net income (loss), diluted			$ (43,313)	$ 1,786,528
Denominator:
Basic weighted average ordinary shares outstanding	8,125,000	8,125,000	8,125,000	8,041,096
Weighted average ordinary shares outstanding, Diluted	8,125,000	8,125,000	8,125,000	8,125,000
Basic net income (loss) per ordinary share	$ 0	$ 0.12	$ (0.01)	$ 0.22
Diluted net income (loss) per ordinary share	$ 0	$ 0.12	$ (0.01)	$ 0.22

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($) $ / shares in Units, $ in Millions			1 Months Ended			12 Months Ended
	Apr. 02, 2021	Feb. 19, 2021	Oct. 29, 2022	Sep. 27, 2022	Feb. 19, 2021	Dec. 31, 2022
Initial Public Offering (Details) [Line Items]
Description of warrant consists						Each Unit consists of one Class A ordinary share and one-fifth of one redeemable warrant (“Public Warrant”).
Deferred underwriting commissions			$ 5.1	$ 6.3		$ 11.4
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Number of units issued					32,500,000
Gross proceeds (in Dollars)		$ 325
Proceeds form offering costs (in Dollars)		$ 18.5
Deferred underwriting commissions.					$ 11.4
Option to purchase shares		2,000,000
Shares forfeited	500,000
Deferred underwriting commissions						$ 6.5
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Number of units issued					2,500,000
Share issued (in Dollars per share)		$ 10			$ 10
Class A Ordinary Shares [Member]
Initial Public Offering (Details) [Line Items]
Class of warrant or right, exercise price of warrants or rights						$ 11.5

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

1 Months Ended

12 Months Ended

May 24, 2022

Jul. 15, 2021

Apr. 02, 2021

Apr. 02, 2021

Feb. 19, 2021

Feb. 16, 2021

Feb. 16, 2021

Dec. 28, 2020

Dec. 28, 2020

Dec. 31, 2022

Dec. 31, 2021

Jan. 31, 2023

Jan. 27, 2023

Oct. 03, 2022

Dec. 23, 2020

Related Party Transactions (Details) [Line Items]

Forfeited shares (in Shares)

1,125,000

1,125,000

Issued and outstanding shares percentage

20%

20%

Generating gross proceeds

$ 8,500,000

Loans Payable

$ 300,000

Outstanding Promissory Note

$ 129,000

Working capital loans

$ 1,500,000

Warrant price per shares (in Dollars per share)

$ 2

Aggregate principal amount

$ 750,000

$ 500,000

Borrowed loans

$ 1,000,000

250,000

Payment for office space

10,000

Incurred expenses

120,000

11,000

Accrued expenses

169,000

100,000

Due to related parties

$ 61,000

$ 61,000

Promissory Note [Member] | Maximum [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument Face Amount

$ 1,250,000

Promissory Note [Member] | Minimum [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument Face Amount

$ 500,000

Over-Allotment Option [Member]

Related Party Transactions (Details) [Line Items]

Issuance of shares (in Shares)

2,500,000

Price per share (in Dollars per share)

$ 10

Private Placement Warrants [Member]

Related Party Transactions (Details) [Line Items]

Issuance of shares (in Shares)

4,250,000

Price per share (in Dollars per share)

$ 2

Generating gross proceeds

$ 8,500,000

Class B Ordinary Shares [Member]

Related Party Transactions (Details) [Line Items]

Issuance of shares (in Shares)

7,906,250

7,906,250

Share dividend (in Shares)

718,750

718,750

Ordinary shares, shares outstanding (in Shares)

8,625,000

8,625,000

Forfeited shares (in Shares)

500,000

500,000

Class B Ordinary Shares [Member] | Maximum [Member]

Related Party Transactions (Details) [Line Items]

Ordinary shares, shares outstanding (in Shares)

8,625,000

8,625,000

Class B Ordinary Shares [Member] | Minimum [Member]

Related Party Transactions (Details) [Line Items]

Ordinary shares, shares outstanding (in Shares)

8,625,000

8,625,000

Class A Ordinary Shares [Member]

Related Party Transactions (Details) [Line Items]

Price per share (in Dollars per share)

$ 11.5

Class A Ordinary Shares [Member] | Private Placement Warrants [Member]

Related Party Transactions (Details) [Line Items]

Price per share (in Dollars per share)

$ 11.5

Founder Shares [Member]

Related Party Transactions (Details) [Line Items]

Initial business combination, description

The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or earlier if, subsequent to the initial Business Combination, the closing price of the Class A ordinary share equals or exceeds $12.00 per share (as adjusted for share sub-divisions, capitalization of shares, share dividends, rights issuances, subdivisions reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, and (B) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

Sponsor [Member]

Related Party Transactions (Details) [Line Items]

Aggregate expenses

$ 25,000

Sponsor [Member] | AR Promissory Note [Member] | Subsequent Event [Member]

Related Party Transactions (Details) [Line Items]

Outstanding Promissory Note

$ 1,250,000

Debt Instrument Interest Rate

0%

Sponsor [Member] | AR Promissory Note [Member] | Subsequent Event [Member] | Maximum [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument Face Amount

$ 1,500,000

Sponsor [Member] | AR Promissory Note [Member] | Subsequent Event [Member] | Minimum [Member]

Related Party Transactions (Details) [Line Items]

Debt Instrument Face Amount

$ 250,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)			1 Months Ended		3 Months Ended	9 Months Ended	12 Months Ended
	Oct. 29, 2022	Sep. 27, 2022	Oct. 29, 2022	Sep. 27, 2022	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies (Details) [Line Items]
Price per unit (in Dollars per share)							$ 0.35
Aggregate amount			$ 5,100,000	$ 6,300,000			$ 11,400,000
Contingent fees							5,200,000	$ 5,000,000
Deferred underwriting fees payable	$ 5,100,000	$ 6,300,000	$ 5,100,000	$ 6,300,000
Derecognition of underwriting fee commissions waived allocated to public shares	5,000,000	6,100,000
Gain loss from settlement of deferred underwriting commissions allocated to derivative warrant liabilities	$ 156,000	$ 190,000			$ 190,190	$ 190,190	$ 345,800	$ 0
IPO [Member]
Commitments and Contingencies (Details) [Line Items]
Price per unit (in Dollars per share)							$ 0.2
Aggregate amount							$ 6,500,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A Ordinary Shares [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Class A Ordinary Shares Subject to Possible Redemption (Details) [Line Items]
Ordinary shares	300,000,000
Ordinary shares par value (in Dollars per share)	$ 0.0001	$ 0.0001
Shares subject to possible redemption	32,500,000	32,500,000
Ordinary shares, vote	one

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption (Details) - Schedule of class A ordinary shares subject to possible redemption - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Schedule of class A ordinary shares subject to possible redemption [Abstract]
Gross proceeds			$ 325,000,000
Less:
Fair value of Public Warrants at issuance			(9,880,000)
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount	$ (4,813,626)	$ (7,492,812)	(17,947,372)
Plus:
Accretion on Class A ordinary shares subject to possible redemption amount			27,827,372
Waiver of offering costs allocated to Class A ordinary shares subject to possible redemption		11,029,200
Class A ordinary shares subject to possible redemption	$ 328,536,388	$ 328,536,388	$ 325,000,000

Shareholders' Deficit (Details)

Shareholders' Deficit (Details)			1 Months Ended					12 Months Ended
	Apr. 02, 2021 shares	Apr. 02, 2021 shares	Feb. 19, 2021	Feb. 16, 2021 shares	Feb. 16, 2021 shares	Dec. 28, 2020 shares	Dec. 28, 2020 shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 $ / shares shares
Shareholders' Deficit (Details) [Line Items]
Preference shares authorized								1,000,000	1,000,000
Preference shares par value | $ / shares								$ 0.0001	$ 0.0001
Preference shares issued or outstanding, description								As of December 31, 2022 and 2021, there were no preference shares issued or outstanding.
Ordinary shares issued and outstanding, description								As of December 31, 2022 and 2021, there were 32,500,000 of Class A ordinary shares issued and outstanding.
Number of vote for each share								1
Ordinary shares, issued								32,500,000	32,500,000
Ordinary shares, outstanding								32,500,000	32,500,000
Forfeited shares				1,125,000	1,125,000
Issued and outstanding shares percentage				20%	20%
Class A Ordinary Shares [Member]
Shareholders' Deficit (Details) [Line Items]
Ordinary shares authorized								300,000,000	300,000,000
Ordinary shares, par value | $ / shares								$ 0.0001	$ 0.0001
Converted basis, percentage								20%
Number of vote for each share								1
Ordinary shares, issued								0	0
Ordinary shares, outstanding								0	0
Class B Ordinary Shares [Member]
Shareholders' Deficit (Details) [Line Items]
Ordinary shares authorized								30,000,000	30,000,000
Ordinary shares, par value | $ / shares								$ 0.0001	$ 0.0001
Ordinary shares, issued								8,125,000	8,125,000
Ordinary shares, outstanding								8,125,000	8,125,000
Issuance of shares (in Shares)						7,906,250	7,906,250
Share dividend				718,750	718,750
Ordinary shares, shares outstanding (in Shares)				8,625,000	8,625,000
Forfeited shares	500,000	500,000
Class B Ordinary Shares [Member] | Minimum [Member]
Shareholders' Deficit (Details) [Line Items]
Ordinary shares, shares outstanding (in Shares)				8,625,000	8,625,000
Class B Ordinary Shares [Member] | Maximum [Member]
Shareholders' Deficit (Details) [Line Items]
Ordinary shares, shares outstanding (in Shares)				8,625,000	8,625,000
Over-Allotment Option [Member]
Shareholders' Deficit (Details) [Line Items]
Issued and outstanding shares percentage			2,500,000%

Warrants (Details)

Warrants (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Warrants (Details) [Line Items]
Warrants exercise price	$ 11.5
Warrant expire term	5 years
Description of additional shares of common stock	In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 10-trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price See “- Redemption of warrants when the price per class A ordinary share equals or exceeds $18.00” and “- Redemption of warrants when the price per class A ordinary share equals or exceeds $10.00” as described below.
Warrant [Member]
Warrants (Details) [Line Items]
Redemption of warrants description	Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):     •   in whole and not in part;     •   at a price of $0.01 per warrant;     •   upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and     •   if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period.
Public Warrants [Member]
Warrants (Details) [Line Items]
Warrants issued	6,500,000	6,500,000
Private Placement [Member]
Warrants (Details) [Line Items]
Warrants issued	4,250,000	4,250,000
Warrants exercise price	$ 2
Class A Ordinary Shares
Warrants (Details) [Line Items]
Warrants exercise price	$ 11.5
Class A Ordinary Shares | Warrant [Member]
Warrants (Details) [Line Items]
Redemption of warrants description	Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):   •   in whole and not in part;   •   at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares;      •   if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and     •   if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
Warrants exercise price	$ 0.361

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Schedule of assets and liabilities measured at fair value on recurring basis - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Assets:
Investments held in Trust Account — money market fund	$ 328,636,388	$ 325,028,452
Quoted Prices in Active Markets (Level 1) [Member]
Assets:
Investments held in Trust Account — money market fund	328,636,388	325,028,452
Liabilities:
Derivative warrant liabilities — Public warrants	0	0
Derivative warrant liabilities — Private placement warrants	0	0
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Investments held in Trust Account — money market fund	0	0
Liabilities:
Derivative warrant liabilities — Public warrants	1,495,000	3,835,000
Derivative warrant liabilities — Private placement warrants	977,500	2,507,500
Significant Other Unobservable Inputs (Level 3) [Member]
Assets:
Investments held in Trust Account — money market fund	0	0
Liabilities:
Derivative warrant liabilities — Public warrants	0	0
Derivative warrant liabilities — Private placement warrants	$ 0	$ 0

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of change in fair value of derivative warrant liabilities	12 Months Ended
	Dec. 31, 2021 USD ($)
Schedule of change in fair value of derivative warrant liabilities [Abstract]
Derivative warrant liabilities, beginning balance	$ 0
Issuance of Public and Private Warrants	16,340,000
Transfer of Public Warrants to Level 1	(8,710,000)
Transfer of Private Warrants to Level 2	(5,695,000)
Change in fair value of derivative warrant liabilities	(1,935,000)
Derivative warrant liabilities, ending balance	$ 0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)		12 Months Ended
	Feb. 08, 2023	Dec. 31, 2021	Dec. 31, 2022
Subsequent Events (Details) [Line Items]
Assets Held-in-trust		$ 325,028,452	$ 328,636,388
Common Stock, Shares, Outstanding		32,500,000	32,500,000
Temporary Equity, Accretion to Redemption Value		$ 27,827,372
Class A Ordinary Shares [Member]
Subsequent Events (Details) [Line Items]
Common Stock, Shares, Outstanding		0	0
Temporary Equity, Redemption Price Per Share		$ 10	$ 10.11
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Assets Held-in-trust	$ 36,200,000
Subsequent Event [Member] | Class A Ordinary Shares [Member]
Subsequent Events (Details) [Line Items]
Common Stock, Shares, Outstanding	3,538,910
Temporary Equity, Accretion to Redemption Value	$ 294.2
Temporary Equity, Redemption Price Per Share	$ 10.16
Stock issued during period, stock options exercised	28,961,090